More research is building against pharmacy benefit managers (PBMs). The American Medical Association (AMA) released a report on Monday that shows there is low competition among PBMs and significant ...
Newly published data suggests low competition among middling players in the pharmaceutical supply chain, with numbers showing that the four largest pharmacy benefit managers in the country control ...
The four largest pharmacy benefit managers in the U.S. control 70% of the national market, and most regional PBM markets are highly concentrated, according to new data from the American Medical ...
The findings may help inform policy changes at the federal level aiming to address unfair and deceptive pharmacy benefit manager (PBM) practices. The pharmacy benefit manager (PBM) market was highly ...
Across industries, competition between a few dominant players is not unusual, but in healthcare, its effects extend well beyond standard business rivalry. When control over prescription drug access ...
Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, drug manufacturers, and pharmacies. This gives them a uniquely powerful ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results